References
- Kohri T, Matsumoto N, Yamakawa M, et al. Metabolic fate of (–)-[4-3H]epigallocatechin gallate in rats after oral administration. J. Agric. Food Chem. 2001;49:4102–4112.10.1021/jf001491+
- Kohri T, Suzuki M, Nanjo F. Identification of metabolites of (−)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 2003;51:5561–5566.10.1021/jf034450x
- Clifford MN, van der Hooft JJJ, Crozier A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am. J. Clin. Nutr. 2013;98:1619S–1630S.10.3945/ajcn.113.058958
- Hara Y. Green tea: health benefits and applications. New York, (NY): CRC Press; 2001.10.1201/CRCFOOSCITEC
- Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X. Molecular targets for the cancer preventive activity of tea polyphenol. Mol. Carcinog. 2006;45:431–435.10.1002/(ISSN)1098-2744
- Takagaki A, Nanjo F. Catabolism of (+)-catechin and (−)-epicatechin by rat intestinal microbiota. J. Agric. Food Chem. 2013;61:4927–4935.10.1021/jf304431v
- Takagaki A, Kato Y, Nanjo F. Isolation and characterization of rat intestinal bacteria involved in biotransformation of (–)-epigallocatechin. Arch. Microbiol. 2014;196:681–695.10.1007/s00203-014-1006-y
- Ito K, Ishida H, Takagaki A, Nanjo F, Maruo T, Ito C. Metabolism of isoflavone from soy bean by Eggerthella sp. MT4s-5, Part 1 Metabolism of daidzein, glycitein, and genistein. Poster session presented at: The Pharmaceutical Society of Japan. 128th Annual Meeting Abstract 2. P. 87; 2008 Mar 26–28; Yokohama, Japan.
- Takagaki A, Nanjo F. Biotransformation of (−)-epigallocatechin and (−)-gallocatechin by intestinal bacteria involved in isoflavone metabolism. Biol. Pharm. Bull. 2015;38:325–330.10.1248/bpb.b14-00646
- Maruo T, Sakamoto M, Ito C, Toda T, Benno Y. Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella. Int. J. Syst. Evol. Microbiol. 2008;58:1221–1227.10.1099/ijs.0.65404-0
- Minamida K, Tanaka M, Abe A, et al. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. J. Biosci. Bioeng. 2006;102:247–250.10.1263/jbb.102.247
- Minamida K, Ota K, Nishimukai M, et al. Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum. Int. J. Syst. Evol. Microbiol. 2008;58:1238–1240.10.1099/ijs.0.64894-0
- Jin J-S, Nishihata T, Kakiuchi N, Hattori M. Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. Biol. Pharm. Bull. 2008;31:1621–1625.10.1248/bpb.31.1621
- Jin J-S, Kitahara M, Sakamoto M, Hattori M, Benno Y. Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol. Int. J. Syst. Evol. Microbiol. 2010;60:1721–1724.10.1099/ijs.0.016774-0
- Matthies A, Blaut M, Braune A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl. Environ. Microbiol. 2009;75:1740–1744.10.1128/AEM.01795-08
- Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch. Microbiol. 2005;183:45–55.10.1007/s00203-004-0747-4
- Bolca S, Verstraete W. Microbial equol production attenuates colonic methanogenesis and sulphidogenesis in vitro. Anaerobe. 2010;16:247–252.10.1016/j.anaerobe.2010.03.002